AMGN Stock Recent News
AMGN LATEST HEADLINES
Amgen (AMGN) closed the most recent trading day at $297, moving +1.38% from the previous trading session.
The latest trading day saw Amgen (AMGN) settling at $296.85, representing a +2.18% change from its previous close.
The Investment Committee give you their top stocks to watch for the second half.
There are a lot of healthcare companies that are investing in GLP-1 weight loss drugs. Today, the leaders in that space are Eli Lilly and Novo Nordisk.
Tech stocks lagged after a very strong first half of the year, while healthcare led the way.
Following quite encouraging news from the laboratory on Monday, Amgen (AMGN 4.07%) was something of a stock market favorite the following day. Its shares closed the trading session more than 4% higher on the back of both that sentiment and a pair of optimistic analyst takes on the latest development.
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Amgen said on Monday its experimental cancer therapy, when combined with chemotherapy, met the main goal in a late-stage trial.
At an Interim Analysis, Bemarituzumab Plus Chemotherapy Significantly Improved Overall Survival in People With FGFR2b Overexpression Compared to Chemotherapy Alone THOUSAND OAKS, Calif. , June 30, 2025 /PRNewswire/ -- Amgen ( NASDAQ:AMGN ) today announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6) met its primary endpoint of overall survival (OS) at a pre-specified interim analysis.
Over the past year, Apple (AAPL 0.04%) and Amgen (AMGN -0.69%), two well-established companies that are part of the iconic Dow Jones Industrial Average, have faced significant headwinds. Apple is struggling due to the threat that President Donald Trump's trade agenda poses to its business, while Amgen faced a clinical setback late last year.